NR3C1 and melanoma: Anti-apoptotic effects of GR agonism were demonstrated in pancreatic, bone, brain, breast, cervix, melanoma, and neuroblastoma cancer cells when combined with a fixed concentration of paclitaxel, cisplatin, or 5-FU [5, 22].